CXCR4 and esophageal squamous cell carcinoma: In addition, Koishi et al. were able to show that persistence of positive CXCR4 expression is implicated in tumor aggressiveness and poor prognosis in esophageal (squamous cell) cancer (ESCC) after neoadjuvant chemoradiotherapy (nCRT) [40].